TR200002567T2 - Glisin naklini önleyiciler. - Google Patents

Glisin naklini önleyiciler.

Info

Publication number
TR200002567T2
TR200002567T2 TR2000/02567T TR200002567T TR200002567T2 TR 200002567 T2 TR200002567 T2 TR 200002567T2 TR 2000/02567 T TR2000/02567 T TR 2000/02567T TR 200002567 T TR200002567 T TR 200002567T TR 200002567 T2 TR200002567 T2 TR 200002567T2
Authority
TR
Turkey
Prior art keywords
transport inhibitors
relates
glycine transport
glycine
diseases
Prior art date
Application number
TR2000/02567T
Other languages
English (en)
Turkish (tr)
Inventor
Herman Maria Louis Luyten Walter
Eduard Janssens Frans
Edmond Josephine Kennis Ludo
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of TR200002567T2 publication Critical patent/TR200002567T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
TR2000/02567T 1998-03-06 1999-02-26 Glisin naklini önleyiciler. TR200002567T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98200701 1998-03-06

Publications (1)

Publication Number Publication Date
TR200002567T2 true TR200002567T2 (tr) 2000-11-21

Family

ID=8233444

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/02567T TR200002567T2 (tr) 1998-03-06 1999-02-26 Glisin naklini önleyiciler.

Country Status (17)

Country Link
EP (1) EP1059922A2 (xx)
JP (1) JP2002505277A (xx)
KR (1) KR20010032968A (xx)
CN (1) CN1292698A (xx)
AU (1) AU3408999A (xx)
BG (1) BG104685A (xx)
BR (1) BR9907951A (xx)
CA (1) CA2322164A1 (xx)
EE (1) EE200000482A (xx)
HR (1) HRP20000523A2 (xx)
HU (1) HUP0101048A2 (xx)
IL (1) IL138228A0 (xx)
NO (1) NO20004431L (xx)
PL (1) PL343435A1 (xx)
SK (1) SK13082000A3 (xx)
TR (1) TR200002567T2 (xx)
WO (1) WO1999044596A2 (xx)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2215670T3 (es) * 1999-06-28 2004-10-16 Janssen Pharmaceutica N.V. Inhibidores de la replicacion del virus sincitial respiratorio.
UA73749C2 (en) * 1999-11-01 2005-09-15 Diarylenines
AU2001254546A1 (en) * 2000-04-20 2001-11-07 Nps Allelix Corp. Aminopiperidines
DE10040016A1 (de) * 2000-08-16 2002-02-28 Boehringer Ingelheim Pharma Neue beta-Amyloid Inhibitoren, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
JP2004508312A (ja) 2000-09-08 2004-03-18 グリアテック　インコーポレイテッド 置換ヒドラジン誘導体
AU2001290786A1 (en) * 2000-09-14 2002-03-26 Gliatech, Inc. Nitrogen-containing compounds and their use as glycine transport inhibitors
AR032653A1 (es) 2001-02-09 2003-11-19 Telik Inc Inhibidores heterociclicos del trasportador de glicina 2 composiciones farmaceuticas, uso y metodos.
US7030150B2 (en) 2001-05-11 2006-04-18 Trimeris, Inc. Benzimidazole compounds and antiviral uses thereof
NZ545454A (en) * 2003-09-09 2009-11-27 Hoffmann La Roche 1-(2-amino-benzoyl)-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
BRPI0413536B8 (pt) 2003-09-09 2021-05-25 Hoffmann La Roche derivados de 1-benzoil-piperazina, seu uso e medicamento que os compreende
WO2005058885A2 (en) * 2003-12-18 2005-06-30 Glaxo Group Limited Piperidine derivatives and their use as glycine transporter inhibitors
TW200630337A (en) 2004-10-14 2006-09-01 Euro Celtique Sa Piperidinyl compounds and the use thereof
ATE430142T1 (de) * 2004-12-09 2009-05-15 Hoffmann La Roche Phenylpiperazin-methanon-derivate
ATE457989T1 (de) 2004-12-15 2010-03-15 Hoffmann La Roche Bi- und trizyklische substituierte phenyl- methanone als inhibitoren von glycin-i (glyt-1)- transportern zur behandlung der alzheimer- krankheit
PE20061156A1 (es) 2004-12-23 2006-12-16 Glaxo Group Ltd Derivados de benzamida como agentes inhibidores del transportador de glicina
GB0428233D0 (en) * 2004-12-23 2005-01-26 Glaxo Group Ltd Compounds
US7485637B2 (en) 2005-01-04 2009-02-03 Hoffmann-La Roche Inc. Benzoyl-tetrahydropiperidine derivatives
CN101356163A (zh) * 2005-01-06 2009-01-28 弗·哈夫曼-拉罗切有限公司 作为甘氨酸转运体1(GlyT-1)抑制剂用于治疗神经学和神经精神病学障碍的硫烷基取代的苯甲酮化合物
ATE472327T1 (de) * 2005-01-07 2010-07-15 Hoffmann La Roche Ä4-(heteroaryl)piperazin-1-ylü-(2,5-substituier e phenyl)methanon-derivate als glycin-transporter 1 (glyt-1) hemmer zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
AU2006207650B2 (en) * 2005-01-18 2011-01-27 F. Hoffmann-La Roche Ag 2, 5-disubstituted phenyl methanone derivatives as glycine transporter 1 (GlyT-I) inhibitors for the treatment of neurological and neuropsychiatry disorders
AU2006208547B2 (en) 2005-01-26 2011-02-10 F. Hoffmann-La Roche Ag Phenyl methanone derivatives and their use as glycine transporter 1 inhibitors
ES2334578T3 (es) * 2005-02-07 2010-03-12 F. Hoffmann-La Roche Ag Fenil-metanonas sustituidas por heterociclo como inhibidores del transportador 1 de la glicina.
CN100341871C (zh) * 2005-06-03 2007-10-10 复旦大学 含哌啶结构的有机硫化合物，制备方法和应用
WO2007110449A1 (en) 2006-03-29 2007-10-04 Euro-Celtique S.A. Benzenesulfonamide compounds and their use
WO2007118854A1 (en) 2006-04-13 2007-10-25 Euro-Celtique S.A. Benzenesulfonamide compounds and the use thereof
US8791264B2 (en) 2006-04-13 2014-07-29 Purdue Pharma L.P. Benzenesulfonamide compounds and their use as blockers of calcium channels
EA017471B1 (ru) 2006-11-01 2012-12-28 Пэдью Фарма Л.П. Фенилпропионамидные соединения и их применение
FR2910321B1 (fr) 2006-12-21 2009-07-10 Galderma Res & Dev S N C Snc Gel creme comprenant au moins un retinoide et du peroxyde de benzole
FR2910320B1 (fr) * 2006-12-21 2009-02-13 Galderma Res & Dev S N C Snc Emulsion comprenant au moins un retinoide et du peroxyde de benzole
WO2008124118A1 (en) 2007-04-09 2008-10-16 Purdue Pharma L.P. Benzenesulfonyl compounds and the use therof
WO2009040659A2 (en) 2007-09-28 2009-04-02 Purdue Pharma L.P. Benzenesulfonamide compounds and the use thereof
US8258306B2 (en) * 2007-12-12 2012-09-04 Amgen Inc. Glycine transporter-1 inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4219559A (en) * 1979-01-10 1980-08-26 Janssen Pharmaceutica N.V. N-Heterocyclyl-4-piperidinamines
CA1140119A (en) * 1978-04-03 1983-01-25 Joseph Torremans N-heterocyclyl-4-piperidinamines
PH23995A (en) * 1984-01-09 1990-02-09 Janssen Pharmaceutica Nv 4((bicycle heterocyclyl)-methyl and hetero)piperidines
US4695575A (en) * 1984-11-13 1987-09-22 Janssen Pharmaceutica, N.V. 4-[(bicycle heterocyclyl)-methyl and -hetero]-piperidines
WO1999025353A1 (en) * 1997-11-13 1999-05-27 Merck Sharp & Dohme Limited Therapeutic uses of triazolo-pyridazine derivatives

Also Published As

Publication number Publication date
EE200000482A (et) 2002-02-15
EP1059922A2 (en) 2000-12-20
KR20010032968A (ko) 2001-04-25
PL343435A1 (en) 2001-08-13
CN1292698A (zh) 2001-04-25
WO1999044596A3 (en) 2000-02-17
CA2322164A1 (en) 1999-09-10
BR9907951A (pt) 2001-01-30
BG104685A (en) 2001-04-30
IL138228A0 (en) 2001-10-31
JP2002505277A (ja) 2002-02-19
HRP20000523A2 (en) 2001-02-28
HUP0101048A2 (hu) 2001-10-28
SK13082000A3 (sk) 2001-03-12
AU3408999A (en) 1999-09-20
NO20004431L (no) 2000-10-30
NO20004431D0 (no) 2000-09-05
WO1999044596A2 (en) 1999-09-10

Similar Documents

Publication Publication Date Title
TR200002567T2 (tr) Glisin naklini önleyiciler.
TR200002570T2 (tr) Glisin naklini önleyiciler
EA200200183A1 (ru) Композиция, содержащая трамадол и противосудорожное лекарственное средство
IS4819A (is) Nýstárlegar staðgengnar hringamínósýrur notaðar til lyfjagerðar
IL125562A0 (en) Novel cyclic amino acids and pharmaceutical compositions comprising them
IL125364A0 (en) Novel bridged cyclic amino acids and pharmaceutical compositions containing them
ATE334668T1 (de) Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
HRP970560B1 (en) Substituted gamma aminobutyric acids as pharmaceutical agents
DE60142236D1 (de) Substituierte 5-alkinyl-pyrimidine mit neurotropher wirkung
DE59209704D1 (de) 2-Aminomethyl-chromane als Wirkstoffe in Arzneimitteln zur Behandlung von Erkrankungen des Zentralnervensystems
GB0129260D0 (en) Pharmaceutical compositions and their uses
DE69223965T2 (de) Anticonvulsives aminosäurederivat
NL300232I1 (nl) Gebruik van daptomycine.
ATE409028T1 (de) Arzneien zur behandlung von nervenerkrankungen
HK1079688A1 (en) Statin product for enhancing cognitive maintenance
BG102080A (en) Amino acid derivatives of substituted quinoxalin 2,3-dion derivatives such as glutamate receptor antagonists
PL336897A1 (en) Novel salts of bpc peptides, pharmaceutic compositions conatining them and method of obtaining such salts
WO2003037335A8 (en) 5-heteroatom-substituted pyrazoles
NZ268914A (en) Use of efaroxan and derivatives to prepare medicaments for treating neurodegenerative diseases especially alzheimer's disease
CA2245647A1 (en) Novel bridged cyclic amino acids as pharmaceutical agents